Literature DB >> 26852440

MATERNAL HYPOTENSION AND NEONATAL ACIDAEMIA DURING CAESEREAN DELIVERY UNDER SPINAL ANAESTHESIA.

P R Olang1, D C Wamalwa.   

Abstract

OBJECTIVES: To determine the incidence of neonatal acidaemia following delivery through caesarean section under spinal anaesthesia and determine the prevalence of maternal hypotension during Caesarean section under spinal anaesthesia and its correlation with neonatal acidaemia.
DESIGN: Prospective observational study.
SETTING: Kenyatta National Hospital (KNH), Nairobi, Kenya.
SUBJECTS: One hundred and seventy-two ASA I and II consecutive term patients undergoing elective Caesarean section under spinal anaesthesia.
RESULTS: Forty three babies (27.2%) were born with neonatal acidaemia, defined as umbilical arterial blood pH 7.2. There was, however, no significant difference in the five minute Apgar scores between the acidotic and non-acidotic neonates. Twenty eight patients (17.7%) developed maternal hypotension (systolic Blood Pressure less than 100mmHg). The hypotension was readily corrected within two minutes (mean of 1.43 minutes) of onset using vasopressors and boluses of intravenous fluids.
CONCLUSIONS: A short period (< 2 minutes) mean of 1.43 minutes of maternal hypotension has no significant effect on the neonate as assessed by five minute Apgar Scores. Similarly, neonatal acidaemia following Caesarean delivery under spinal anaesthesia does not seem to have any short-term effects on neonatal well-being.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 26852440

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  1 in total

1.  Impact of interval between induction of spinal anesthesia to delivery on umbilical arterial cord ph of neonates delivered by elective cesarean section.

Authors:  Alaa S Hassanin; Hazem F El-Shahawy; Sherif Hanafi Hussain; Ahmed M Bahaa Eldin; Marwa Mohammed Elhawary; Mohamed Elbakery; Mohammed S E Elsafty
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-17       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.